118 related articles for article (PubMed ID: 15001837)
1. Antisense oligodeoxynucleotide directed against c-myb has anticancer activity and potentiates the antiproliferative effect of conventional anticancer drugs acting by different mechanisms in human colorectal cancer cells.
Abaza MS; Al-Attiyah RJ; Al-Saffar AM; Al-Sawan SM; Moussa NM
Tumour Biol; 2003; 24(5):241-57. PubMed ID: 15001837
[TBL] [Abstract][Full Text] [Related]
2. c-myc antisense oligonucleotides sensitize human colorectal cancer cells to chemotherapeutic drugs.
Abaza MS; Al-Saffar A; Al-Sawan S; Al-Attiyah R
Tumour Biol; 2008; 29(5):287-303. PubMed ID: 18802399
[TBL] [Abstract][Full Text] [Related]
3. Effect of cisplatin and c-myb antisense phosphorothioate oligodeoxynucleotides combination on a human colon carcinoma cell line in vitro and in vivo.
Del Bufalo D; Cucco C; Leonetti C; Citro G; D'Agnano I; Benassi M; Geiser T; Zon G; Calabretta B; Zupi G
Br J Cancer; 1996 Aug; 74(3):387-93. PubMed ID: 8695353
[TBL] [Abstract][Full Text] [Related]
4. Delivery of c-myb antisense oligodeoxynucleotides to human neuroblastoma cells via disialoganglioside GD(2)-targeted immunoliposomes: antitumor effects.
Pagnan G; Stuart DD; Pastorino F; Raffaghello L; Montaldo PG; Allen TM; Calabretta B; Ponzoni M
J Natl Cancer Inst; 2000 Feb; 92(3):253-61. PubMed ID: 10655443
[TBL] [Abstract][Full Text] [Related]
5. Targeted delivery of oncogene-selective antisense oligonucleotides in neuroectodermal tumors: therapeutic implications.
Pastorino F; Brignole C; Marimpietri D; Di Paolo D; Zancolli M; Pagnan G; Ponzoni M
Ann N Y Acad Sci; 2004 Dec; 1028():90-103. PubMed ID: 15650235
[TBL] [Abstract][Full Text] [Related]
6. Targeted delivery system for antisense oligonucleotides: a novel experimental strategy for neuroblastoma treatment.
Brignole C; Pagnan G; Marimpietri D; Cosimo E; Allen TM; Ponzoni M; Pastorino F
Cancer Lett; 2003 Jul; 197(1-2):231-5. PubMed ID: 12880987
[TBL] [Abstract][Full Text] [Related]
7. Synergistic chemsensitization and inhibition of tumor growth and metastasis by the antisense oligodeoxynucleotide targeting clusterin gene in a human bladder cancer model.
Miyake H; Hara I; Kamidono S; Gleave ME
Clin Cancer Res; 2001 Dec; 7(12):4245-52. PubMed ID: 11751526
[TBL] [Abstract][Full Text] [Related]
8. Antisense TRPM-2 oligodeoxynucleotides chemosensitize human androgen-independent PC-3 prostate cancer cells both in vitro and in vivo.
Miyake H; Chi KN; Gleave ME
Clin Cancer Res; 2000 May; 6(5):1655-63. PubMed ID: 10815883
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of leukaemia cell proliferation by folic acid-polylysine-mediated introduction of c-myb antisense oligodeoxynucleotides into HL-60 cells.
Citro G; Szczylik C; Ginobbi P; Zupi G; Calabretta B
Br J Cancer; 1994 Mar; 69(3):463-7. PubMed ID: 8123474
[TBL] [Abstract][Full Text] [Related]
10. Antitumor effect of bcl-2 antisense phosphorothioate oligodeoxynucleotides on human renal-cell carcinoma cells in vitro and in mice.
Uchida T; Gao JP; Wang C; Satoh T; Itoh I; Muramoto M; Hyodo T; Irie A; Akahoshi T; Jiang SX; Kameya T; Baba S
Mol Urol; 2001; 5(2):71-8. PubMed ID: 11690551
[TBL] [Abstract][Full Text] [Related]
11. Roscovitine synergizes with conventional chemo-therapeutic drugs to induce efficient apoptosis of human colorectal cancer cells.
Abaza MS; Bahman AM; Al-Attiyah RJ
World J Gastroenterol; 2008 Sep; 14(33):5162-75. PubMed ID: 18777593
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of proliferation by c-myb antisense oligodeoxynucleotides in colon adenocarcinoma cell lines that express c-myb.
Melani C; Rivoltini L; Parmiani G; Calabretta B; Colombo MP
Cancer Res; 1991 Jun; 51(11):2897-901. PubMed ID: 2032228
[TBL] [Abstract][Full Text] [Related]
13. c-myc antisense oligodeoxynucleotides enhance the efficacy of cisplatin in melanoma chemotherapy in vitro and in nude mice.
Citro G; D'Agnano I; Leonetti C; Perini R; Bucci B; Zon G; Calabretta B; Zupi G
Cancer Res; 1998 Jan; 58(2):283-9. PubMed ID: 9443406
[TBL] [Abstract][Full Text] [Related]
14. Targeting c-Myb expression in human disease.
Ramsay RG; Barton AL; Gonda TJ
Expert Opin Ther Targets; 2003 Apr; 7(2):235-48. PubMed ID: 12667100
[TBL] [Abstract][Full Text] [Related]
15. Tumor growth inhibition in vivo and G2/M cell cycle arrest induced by antisense oligodeoxynucleotide targeting thymidylate synthase.
Berg RW; Werner M; Ferguson PJ; Postenka C; Vincent M; Koropatnick DJ; Behrend E
J Pharmacol Exp Ther; 2001 Aug; 298(2):477-84. PubMed ID: 11454908
[TBL] [Abstract][Full Text] [Related]
16. c-Myb regulates NOX1/p38 to control survival of colorectal carcinoma cells.
Pekarčíková L; Knopfová L; Beneš P; Šmarda J
Cell Signal; 2016 Aug; 28(8):924-36. PubMed ID: 27107996
[TBL] [Abstract][Full Text] [Related]
17. An oligomer complementary to c-myb-encoded mRNA inhibits proliferation of human myeloid leukemia cell lines.
Anfossi G; Gewirtz AM; Calabretta B
Proc Natl Acad Sci U S A; 1989 May; 86(9):3379-83. PubMed ID: 2541445
[TBL] [Abstract][Full Text] [Related]
18. c-erbB2 and c-myb induce mouse oocyte maturation involving activation of maturation promoting factor.
Zheng LP; Huang J; Zhang DL; Xu LQ; Li F; Wu L; Liu ZY; Zheng YH
DNA Cell Biol; 2012 Feb; 31(2):164-70. PubMed ID: 21793718
[TBL] [Abstract][Full Text] [Related]
19. Immune cell-mediated antitumor activities of GD2-targeted liposomal c-myb antisense oligonucleotides containing CpG motifs.
Brignole C; Pastorino F; Marimpietri D; Pagnan G; Pistorio A; Allen TM; Pistoia V; Ponzoni M
J Natl Cancer Inst; 2004 Aug; 96(15):1171-80. PubMed ID: 15292389
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of in vitro proliferation of chronic myelogenous leukemia progenitor cells by c-myb antisense oligodeoxynucleotides.
Szczylik C; Skórski T; Malaguarnera L; Hetman J; Chen ST; Calabretta B
Folia Histochem Cytobiol; 1996; 34(3-4):129-34. PubMed ID: 8967957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
